Thalidomide for the treatment of angiodysplasia‐related recurrent gastrointestinal hemorrhage: Is low dose a safe and viable option?

Thalidomide is often used for the management of refractory gastrointestinal angiodysplasia (GIAD). The tolerance, toxic profile, and compliance of thalidomide are dose‐dependent. The low‐dose thalidomide (50 mg) is safe and a viable option for bleeding related to GIAD.

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Case Rep
Main Authors: Patel, Harish, Mehershahi, Shehriyar, Shaikh, Danial Haris, Makker, Jasbir, Nayudu, Sureshkumar, Remy, Prospere, Chilimuri, Sridhar
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6935600/
https://ncbi.nlm.nih.gov/pubmed/31893059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2501
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados